09.04.2020
- US President Donald Trump’s relentless promotion of the 86-year-old generic drug hydroxychloroquine, used successfully to treat malaria, lupus and rheumatoid arthritis, as an...
07.04.2014
- Swedish generic drugmaker Meda has rejected a takeover approach by U.S. rival Mylan to create a combined company worth around $24 billion. Reports said Mylan was exploring a bid at...
